Zynerba Pharmaceuticals Inc. (ZYNE) gained 12.35% or 0.9 to $8.19. It is near 1.31 million shares traded, which is 242.88% compare to the average total volume 538565. The market cap of ZYNE is $144.34 million. The year to date change is -31.56%. The 52 week price range is from $5.59 to $15.13. Price of ZYNE have changed 4.44% during last week. It have changed 16.08% over last month, -34.97% over last 3 months, -22.36% over last 6 months and 13.55% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for ZYNE is 7.40. It is -9.65% below current price. The 200-day Moving Averages for ZYNE is 9.90. It is 20.88% above current price. The 52-week High is 15.13. It is 84.74% from the current price. The 52-week Low is 5.59. It is -31.75% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of ZYNE is 2.59 on 2018-08-31. Short % to float is 11.50%. There are some statistics of ZYNE. It is has market cap $144.34 million. The share outstanding is 17.62 million. The average volume is 538565. The percent of top 15 Institution holding is 14.10%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of ZYNE is -73.21%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of ZYNE is -62.06%.